Scholars Central

Conference abstractPublished 29 Jul 2019

Comparison of 5-Fluorouracil and Mitomycin-C in primary treatment of ocular surface squamous neoplasia

Authors: Akanksha Darda

India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Aim: To compare efficacy and safety of topical 5-Fluorouracil 1% (5-FU) and Mitomycin C 0.04% (MMC) for Ocular Surface Squamous Neoplasia (OSSN). Method: This retrospective study included 48 patients of primary OSSN. All were treated with 5-FU or MMC. Primary outcome measure was frequency of complete clinical resolution and recurrence rate. Other outcome measures included duration of treatment and adverse effects. Results: 22 eyes were treated with 5-FU and 26 with MMC. Complete response was achieved in 86% and 81% eyes with 5-FU and MMC, respectively (P=0.67). Patients were treated with median of three cycles in both groups. Tumor recurrence rate was 7.6% in MMC group while none in 5-FU. The median follow-up after resolution was eight months in 5-FU vs 10 months in MMC. Adverse effects were 18% in 5-FU and 58% in MMC group (P<0.005). Conclusion: Both 5-FU and MMC seemed to be equally effective for treatment of OSSN. 5-FU can be preferred as it has lower recurrence rate with minimal side effects over MMC.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Experimental Ophthalmology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Experimental Ophthalmology
  • SubjectOphthalmology & Optometry
  • BylineArticles whose byline prints “Akanksha Darda”